Purpose/ Objective

Kawasaki disease (KD) is an acute idiopathic form of childhood vasculitis that can result in coronary artery aneurysms.  Although it is one of the leading cause of acquired heart disease in children, KD sequelae can be difficult to assess by standard non-invasive imaging techniques. Takeyasu arteritis is also an idiopathic form of inflammatory vasculitis that more commonly affects larger arteries and is also difficult to assess by standard imaging techniques. CMR can improve the clinician’s understanding of coronary artery and vascular wall anatomy in patients with KD or vasculitis such as Takeyasu arteritis, particularly with regards to later sequelae of disease. Following this session, learners will better understand, what are the most common types of vascular diseases in children, how to assess coronary arteries by CMR in subjects with a history of Kawasaki Disease, and what are CMR characteristics of the vessel wall in Kawasaki Disease and in Takayasu arteritis.

Accreditation Statement

The Society for Cardiovascular Magnetic Resonance (SCMR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The Society for Cardiovascular Magnetic Resonance (SCMR) designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Claiming CME

• Attend the sessions in full for which credit is sought
• Complete the post-activity evaluation
• A certificate of completion will be available once the evaluation is submitted

Financial Disclosures

The planners and faculty for this activity did not have any relevant relationships to disclose.

Disclosure of Commercial Support

SCMR received no funding to support this activity.

Bibliography

• Jiang et al. International Journal of Cardiology 2012;115:262-267
• Tangcharown T., Greil GF Radiology 2011;259(1):240-247
• Tangcharown T. et al. Radiology 2011 April:259(1)
• Greil GF et al. Circulation 2002;105;908-911
• Mavrogeni S. JACC 2004;43(4):649-52
• Suzuki A. Cardiol Young 2006 Dec;16(6):563-71
• Hussain et al. JMRI 2011;34:279-285
• Greil GF et al. Pediatr Radiol 2007;37:666-673
• Hussain T et al. Circulation: Cardiovascular Imaging 2013 Jan 1;6(1):91-8
• Suzuki et al. Circulation 2000;101:2935-2941
• Greil GF et al. JCMR 2007;9(1):49-56
• Kim WY, Danias PG, Stuber M, et al.: N Engl J Med 2001;345(26):1863-1869
• Miyagawa et al. Circulation 1998 Sep 8;98(10):990-6
• Mavrogeni S. et al. Int J Cardiovase Imaging 2013 Aug 15
• Oates-Whitehead RM, et al. IVIG for the treatment of KD in Children Cochrane Database System Rev. 2003;(4):CD004000
• Weiss PF Pediatric Vasculitis Pediatr Clin North Am 2012 Apr;59(2):407-23
• Jamieson N, Singh-Grewal D. Kawasaki Disease: A Clinician’s Update. Int J Pediatr 2013;2013:645391
• Baumer JH, et al. Salicylate for the treatment of KD in Children Cochrane Datatbase Syst Rev 2006:(4):CD004175
• Tacke CE et al. Circ CVI 2013;6:67-73
• Tacke CE et al Circ CVI 2011;4:712-20
• Mavrogeni S, et al. JACC CVI 2011;4:1140-1
• Arend et al. Arthritis Rheum 1990;33:1129-34
• Ginde et al. JACC 2012;59:e23
• Andrews J and Mason JC Rheumatology 2007;46:6-15
• Meini et al. Circulation 2006;114:e544
• Gomik HL and Creager MA Circulation 2008;117:3039-3051
• Keenan NG et al, Arthritis & Rheumatism 2009 Nov;60:3501-3509
• Li et al. J Comput Assist Tomogr 2001;35:468-74